WHO Working Group Meeting to discuss the Revision of the WHO Recommendations for OPV: TRS No. 904 and 910, Geneva, Switzerland, 20-22 July 2010

IABS Scientific Workshop on Neurovirulence Tests for Live Virus Vaccines

WHO, Geneva, Switzerland, 31 January-1 February 2005

Polio vaccine containment meeting report

July 2003

Communication for polio eradication and routine immunization. Checklists and easy reference guides

Global Polio Eradication Initiative Progress 2003

Guidelines for implementing the pre-eradication phase of the global action lan for laboratory containment of wild pilioviruses

Surveying laboratories. Establishing inventories. April 2000

Global Polio Eradication Initiative Strategic Plan 2004-2008

Making use of vaccine vial monitors. Flexible vaccine management for polio supplementary immunization acitivities

New polio vaccines for the post-eradication era

Geneva, 19-20 January 2000

Fourth informal consultation on the polio laboratory network

Geneva, 1-2 October 1998

WHO global action plan for laboratory containment of wild polioviruses

Global eradication of polio: Report of the meeting on the scientific basis for stopping polio immunization

Geneva, 23-25 March 1998

Polio: the beginning of the end




  • WHO Informal Consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products including biosimilars, Seoul, Republic of Korea, 27-28 April 2017
  • Working Group meeting on revision of WHO TRS 941, Annex 5: WHO biosafety risk assessment and Guidelines for the production and quality control of human influenza pandemic vaccines, Geneva, Switzerland, 9-10 May 2017
  • Working group meeting on Hepatitis E Vaccine, Geneva, Switzerland, 11-12 May 2017


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971